The Carlyle Group Ends Year on a High Note; Three Chinese Portfolio Companies Raised Nearly US$780 Million through Successful IPOs

Hong Kong – Global private equity firm The Carlyle Group today announced that three of its portfolio companies managed by the Carlyle Asia Growth Capital Partners have successfully completed their initial public offerings (IPO) in Hong Kong and in New York this month, raising a combined total of nearly US$780 million in gross proceeds. China Forestry Holdings Co., Ltd., Kaisa Group Holdings Ltd., and Concord Medical Services Holdings Ltd. have all seen active trading.

Wayne Tsou, Managing Director and Head of the Carlyle Asia Growth Capital group, said, "These IPOs are milestones for China Forestry, Kaisa and Concord. The broad participation in the IPOs by a large number of quality institutions and retail investors stands testament to the strong growth potential of these companies and their leadership in the market.”

“Carlyle is proud to have supported each of these companies with global resources and management expertise to help realize their business and strategic initiatives. As an ongoing long-term investor, we do not view these IPOs as exit events and have not reduced our stake through any of these IPOs. Looking ahead, we remain committed to helping these companies fulfill their strategic and commercial objectives just as we are committed to China for the long-term," added Tsou.

China Forestry (0930.HK) is one of the three largest privately-held naturally regenerated and plantation forest operators in China, based on coverage area of owned forest rights. It manages and develops sustainable forests for harvesting and sales. All of its logs are sold domestically for construction, furniture, interior decoration, wood products and paper industries. Listed on the Hong Kong Stock Exchange on December 3, 2009, China Forestry raised total gross proceeds of US$200 million from the IPO.

Headquartered in Shenzhen, Kaisa (1638.HK) is a leading developer in China’s Pearl River Delta region with one of the largest land banks in Greater Shenzhen area. Kaisa, listed on the Hong Kong Stock Exchange on December 9, 2009, successfully raised US$445 million of gross proceeds and attracted a number of large investors from the property sector and major institutions. Kaisa is jointly invested by the Carlyle Asia Growth Capital Partners and the Carlyle Asia Real Estate Partners.

Concord (NYSE: CCM) operates the largest network of radiotherapy and diagnostic imaging centers for cancer treatment and diagnosis in China in terms of revenue and the total number of centers in operation in 2008. Listed on the New York Stock Exchange on December 11, 2009, it has raised total gross proceeds of US$132 million from the IPO.

# # #